GATAD2B and breast cancer: Similarly, reducing O-GlcNAcylation on GATAD2B by mutating potential modification Serines to Alanines also shortens GATAD2B half-life and increases ubiquitination level of GATAD2B, subsequently impairs mammosphere formation of breast cancer cells.